Endoo · Project

Robotic Painless Colonoscopy System to Boost Colorectal Cancer Screening Rates

healthTestedTRL 6

Colonoscopies save lives by catching colorectal cancer early, but many people skip them because the procedure is uncomfortable and often painful. The Endoo team built a robotic colonoscope that uses magnets to gently guide a soft, flexible tube through the colon — no pushing, no pain, no sedation needed. Think of it like the difference between forcing a garden hose around corners versus steering it smoothly with a magnet from the outside. The goal is to make screening so easy that far more people actually show up for it.

By the numbers

consortium partners

countries involved (DE, IT, UK)

industrial partners in the consortium

SMEs in the consortium

44%

industry ratio in consortium

The business problem

What needed solving

Colorectal cancer is one of the major causes of mortality, yet survival rates increase dramatically with early diagnosis. Current screening colonoscopy suffers from low patient uptake because the procedure is invasive, painful, requires sedation, and depends heavily on operator skill. These barriers consistently limit the reach of mass screening campaigns, meaning cancers are caught too late.

The solution

What was built

The project built an integrated robotic platform featuring a magnetic-driven, soft-tethered colonoscope with both diagnostic and therapeutic capabilities. The final deliverable was a complete demonstration of the integrated Endoo platform in a session simulating a real medical intervention, showing all functionalities including active navigation, diagnosis, and treatment.

Audience

Who needs this

Endoscopy equipment manufacturers looking to add robotic colonoscopy to their product lineHospital networks and ambulatory surgery centers running high-volume GI screening programsNational health services and insurers funding colorectal cancer screening campaignsMedical robotics companies seeking proven magnetic navigation technologyGastroenterology clinic chains expanding into painless screening services

Business applications

Who can put this to work

Medical device manufacturing

enterprise

Target: Colonoscope and endoscopy equipment manufacturers

If you are a medical device company producing endoscopy equipment and struggling with slow adoption of screening colonoscopy due to patient discomfort — this project developed a magnetic-driven robotic colonoscope platform that enables painless navigation without sedation. The integrated system was demonstrated in a simulated real medical intervention with a consortium of 9 partners including 4 industrial players. This could be licensed or co-developed to add a robotic product line to your existing endoscopy portfolio.

Healthcare services

enterprise

Target: Hospital networks and ambulatory surgery centers running GI screening programs

If you are a hospital network or screening center dealing with low patient compliance for colonoscopy and high costs from sedation and recovery — this project built a robotic system designed to make colonoscopy painless and less operator-dependent. The platform reduces the need for sedation, which cuts procedure time and recovery costs. With 4 university partners and 4 SMEs behind the technology, the system was designed specifically for mass screening workflows.

Public health and insurance

enterprise

Target: National health services and insurance companies funding cancer screening programs

If you are a public health authority or insurer funding colorectal cancer screening campaigns and facing low participation rates due to patient fear and discomfort — this project developed a painless robotic colonoscopy platform built for mass screening. The system reduces dependence on highly skilled operators, which could expand screening capacity in underserved regions. The consortium of 9 partners across 3 countries designed it with clinical deployment in mind.

Frequently asked

Quick answers

What would this robotic colonoscopy system cost compared to conventional equipment?

The project data does not include specific pricing or cost estimates for the Endoo platform. Based on available project data, the system was designed to reduce overall procedure costs by eliminating sedation and shortening recovery time, but exact figures would need to come from the consortium partners.

Can this system handle the volume needed for mass screening programs?

The Endoo platform was explicitly designed for mass screening campaigns, addressing the factors that limit current screening pervasiveness — pain, sedation requirements, and operator skill dependence. The final demonstration showed all functionalities in a simulated real medical intervention. Scaling to clinical volumes would depend on regulatory clearance and manufacturing partnerships.

What is the IP situation and can this technology be licensed?

The project objective states the consortium built on 'solid and IPR protected technologies provided by the Project Partners.' With 4 industrial partners and 4 SMEs in the consortium, IP is likely distributed among multiple entities. Licensing discussions would need to go through the coordinator at Scuola Superiore Sant'Anna in Italy.

What regulatory approvals does this system need before clinical use?

As a robotic medical device for internal use, the Endoo platform would require CE marking under the EU Medical Device Regulation and FDA clearance for the US market. The project included certification and market analysis activities, but based on available project data, regulatory approval status after the project ended in 2019 is not documented.

How long before this technology could be deployed in a clinical setting?

The project ran from December 2015 to May 2019 and completed a final integrated platform demonstration simulating a real medical intervention. The consortium's stated aim was to bring the system to market for extensive clinical use. Post-project commercialization timelines would depend on regulatory processes and manufacturing scale-up.

Does this replace existing colonoscopy equipment or integrate with it?

The Endoo system is designed as an integrated robotic platform — a new approach to colonoscopy rather than an add-on to existing equipment. It combines magnetic-driven navigation with diagnostic and therapeutic capabilities. Integration with existing hospital IT and endoscopy suite infrastructure would need to be assessed with the consortium.

Consortium

Who built it

The Endoo consortium is well-balanced for bringing a medical robotic device to market, with 9 partners across Germany, Italy, and the UK. The 44% industry ratio — 4 industrial partners including 4 SMEs — shows strong commercial intent alongside the 4 university partners providing research depth and 1 research organization. The coordinator, Scuola Superiore Sant'Anna in Pisa, is internationally recognized in robotics and biomedical engineering. The mix of agile SMEs and established academic institutions suggests the technology has both scientific rigor and a realistic path toward manufacturing and certification.

SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNACoordinator · IT
UNIVERSITA DEGLI STUDI DI TORINOparticipant · IT
LOTHIAN HEALTH BOARDthirdparty · UK
EKYMED SRLparticipant · IT
UNIVERSITY COLLEGE LONDONparticipant · UK
OVESCO ENDOSCOPY AGparticipant · DE
THE UNIVERSITY OF EDINBURGHparticipant · UK

How to reach the team

Scuola Superiore Sant'Anna, Pisa, Italy — reach out to the BioRobotics Institute or project coordination office

Order a report on this consortium See SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA profile →

Next steps

Talk to the team behind this work.

Want an introduction to the Endoo consortium to discuss licensing, partnership, or clinical deployment? SciTransfer connects businesses with EU research teams — contact us for a tailored briefing.

Order a report on this topic More in Health & Biomedical